Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Lanxin Computing | 2026 | Series A | $14.4M | Shenzhen |
| Tauren | 2026 | Series E | Undisclosed | Pudong |
| Raysees | 2026 | Series C | Undisclosed | Shenzhen |
| Xvisio Technology | 2026 | Series B | Undisclosed | Shanghai |
| IPLUSMOBOT | 2026 | Series C | $25.8M | Hangzhou |
| Cryofocus Biotech | 2026 | Post Ipo Equity | $5.1M | Shanghai |
| SaDa Robotics | 2026 | Seed | $1.4M | Suzhou |
| Ninetech | 2026 | Series B | $14.3M | Shenzhen |
| Weiyuan Synthetic Biotechnology | 2026 | Series Unknown | $42.9M | Beijing |
| Booster Robotics | 2025 | Series Unknown | Undisclosed | Beijing |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Lanxin Computing | Series A | $14.4M | Shenzhen, China |
| 27 | Tauren | Series E | Undisclosed | Pudong, China |
| 28 | Raysees | Series C | Undisclosed | Shenzhen, China |
| 29 | Xvisio Technology | Series B | Undisclosed | Shanghai, China |
| 30 | IPLUSMOBOT | Series C | $25.8M | Hangzhou, China |
| 31 | Cryofocus Biotech | Post Ipo Equity | $5.1M | Shanghai, China |
| 32 | SaDa Robotics | Seed | $1.4M | Suzhou, China |
| 33 | Ninetech | Series B | $14.3M | Shenzhen, China |
| 34 | Weiyuan Synthetic Biotechnology | Series Unknown | $42.9M | Beijing, China |
| 35 | Booster Robotics | Series Unknown | Undisclosed | Beijing, China |
Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
Tauren is a domestic and hybrid design enterprise of analog and analog-digital chips.
Raysees is a technology company that develops lighting technologies and optical chip products.
Xvisio Technology provide services in computer vision solution for VSLAM total solution.
IPLUSMOBOT is one of the global leading companies in the autonomous mobile robot field
Cryofocus Biotech cryoablation device manufacturer.
Sada Robotics designs and manufactures intelligent robots for new energy operations and maintenance.
Ninetech provides digital transformation and upgrading solutions for large state-owned enterprises and central enterprises.
Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.
Booster Robotics is a developer of robots that focuses on artificial intelligence and multi-dimensional modes and control strategies.
Xingyi Space focuses on spacecraft measurement, control, and operations; space control software; and integrated space solutions.
MAXVAX aims to provide novel vaccine development and commercialization.
Wellari specialized in the research, development, and manufacture of metal 3D printing powder.
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals.
SAGE Intelligent is a composite robot manufacturer.
ENCOS is a developer of high-performance robot integrated joint modules.
Shouxing Technology is the developer of the Humanoid robot.
Shixin Materials conducts research and development, production and sales of carbon-ceramic composite materials and their products.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Maixi Software is a software engineering firm specializing in computer-aided engineering and optimization tools.
Weike Bio is a gene therapy drug development company.
Yunmai Xinlian is a developer of chips designed for data center network.
ATAPEX focuses on the research and development, manufacturing and supporting services of high-precision metal masks.
Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
Shenzhen Capital Group has invested in 277 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Shenzhen Capital Group's top investment sectors include Manufacturing, Semiconductor, Robotics, Health Care, Biotechnology. The firm invests across 34 different industry categories.
Among tracked funding rounds, Sanegene Bio received $110.0M in a Series B round. Shenzhen Capital Group's total known invested capital is $5.7B.
Shenzhen Capital Group's average investment size is $32.2M across its portfolio of 277 companies.
Recent Shenzhen Capital Group portfolio additions include Lanxin Computing, Tauren, Raysees, Xvisio Technology, IPLUSMOBOT. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors